ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

NIH Signs Agreement For Use Of Five Stem Cell Lines.

September 7, 2001

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974

RFP To Be Issued For Two More Neutron Therapy Facilities; Winners To Conduct Clinical Trials

October 27, 1978

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady Wins RSNA Medal

January 5, 1990